Under-Aged Donor Informed Consent for Allogeneic Bone Marrow Transplantation in the European Union (E.U.) Countries. Legal Aspects

Pediatric Research - United States
doi 10.1203/00006450-199905010-00085
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Allogeneic Bone Marrow Transplantation for Alexander’s Disease

Bone Marrow Transplantation
TransplantationHematology
1997English

Allogeneic Bone Marrow Transplantation for Advanced Waldenstrom’s Macroglobulinemia

Bone Marrow Transplantation
TransplantationHematology
1999English

Bone Mineral Density After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Aspergillus Tracheobronchitis After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
2000English

Disseminated Nocardiosis After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1997English

Monitoring Soluble Interleukin-2 Receptor Levels in Related and Unrelated Donor Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1998English

Powerful New Strategy for Allogeneic Bone Marrow Transplantation in Mice

The Journal of Kansai Medical University
2002English

Donor T-Lymphocyte Infusion for Unrelated Allogeneic Bone Marrow Transplantation With CD3+ T-Cell-Depleted Graft

Bone Marrow Transplantation
TransplantationHematology
2003English

Donor Lymphocyte Infusion in Bone Marrow Transplantation Therapy

Revista Brasileira de Hematologia e Hemoterapia
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy